Financial report interval: 2025.12.31 - 2026.03.31
Preview: BioKangtai(300601) predict that the Revenue is 631.11 M (-2.18%), Miss estimate;the EBIT is 40.64 M (+44.42%), Miss estimate;the EPS is 0.03 (+50%), Miss estimate.